Rationale and Comments

Asymptomatic hematuria in women is common but less likely to be associated with a urinary tract malignancy compared with men. Data support changing the evaluation requirements for microscopic hematuria in this low-risk group of women. Organizations that do not risk-stratify based on gender may continue to recommend more aggressive diagnostic evaluation in low-risk women.

Sponsoring Organizations

• American Urogynecologic Society

Sources

• Systematic review

Disciplines

• Urologic

References

• Committee on Gynecologic Practice, American Urogynecologic Society. Committee opinion no. 703: asymptomatic microscopic hematuria in women. Obstet Gynecol. 2017;129(6):1153-1154.
  
• Jeppson PC, Jakus-Waldman S, Yazdany T, et al. American Urogynecologic Society Systematic Review: Microscopic Hematuria as a Screening Tool for Urologic Malignancies in Women [published online ahead of print, 2019 Apr 12]. Female Pelvic Med Reconstr Surg. 2019;10.1097/SPV.0000000000000726.
  
• Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188(6 Suppl):2473-2481. (reviewed and reaffirmed in 2016)
  
• Lippmann QK, Slezak JM, Menefee SA, Ng CK, Whitcomb EL, Loo RK. Evaluation of microscopic hematuria and risk of urologic cancer in female patients. Am J Obstet Gynecol. 2017;216:146.e1-146.e7.
  
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7-30.